CURE: DIREXION DAILY HEALTHCARE BULL 3X SHARES
Share-split context: A forward split was recorded on May 20, 2015 with coefficient 4. A forward split turns each old share into multiple new shares and lowers the quoted price per share proportionally. Proportional ownership is unchanged at the split moment, so the split itself creates neither a gain nor a loss. The price-return figures in this report are already split-adjusted.
What this ETF is trying to do
The DIREXION DAILY HEALTHCARE BULL 3X SHARES (ticker: CURE) is an ETF that focuses on the healthcare sector. This is a "leveraged" ETF, which means it is designed to aim for more movement than the standard healthcare index it follows.
What the numbers show
As of October 7, 2026, the current price of one share is $129.79. When looking at how this ETF has performed, it is important to look at two different numbers: price return and total return. Price return only shows how much the share price changed. Total return includes those price changes plus any cash distributions paid to investors.
According to the data:
• Year-to-date (YTD): The price return was approximately 16.34%, while the total return was approximately 17.43%.
• One year: The price return was approximately 40.47%, and the total return was approximately 42.14%.
• Three years: The price return was approximately 42.94%, and the total return was approximately 48.44%.
This ETF has a history of "forward splits." In a forward split, each old share becomes multiple new shares. This causes the price per share to drop, but your total ownership stays the same. A forward split does not mean an investor lost money; it is simply a change in how many shares you own.
Income and distribution explanation
This ETF provides some cash income through distributions. The distribution yield is approximately 0.97%. Over the last 12 months, there were 4 payouts, which usually happen every three months (quarterly). It is important to remember that a high distribution yield does not mean you earned that same percentage as your total return.
NAV erosion explanation
"NAV erosion" refers to a decline in the actual value of the fund's underlying assets. For this ETF, the erosion-risk score is 100, and the label states "No price erosion detected." The severity is rated as "good," and there is no severe erosion-risk flag present.
Top Holdings
The following are the top holdings in this portfolio (note that this list is partial):
• HEALTH CARE SELECT SECTOR INDEX SWAP: 24.05%
• DREYFUS GOVT CASH MAN INS: 19.83%
• ELI LILLY AND CO: 10.64%
• GOLDMAN SACHS FIN GOV 465 INSTITUT: 7.19%
• JOHNSON & JOHNSON: 6.97%
• CASH: 5.47%
• ABBVIE INC: 5.01%
• MERCK & CO INC: 4.04%
• UNITEDHEALTH GROUP INC: 3.79%
• AMGEN INC: 2.54%
Pros
• The ETF has shown positive price and total returns over the last year and three years.
• The erosion-risk score indicates no price erosion was detected.
Cons
• Because this is a leveraged ETF, it is designed for more intense price movements.
• The provided list of holdings is only a partial view of the full portfolio.
Beginner takeaway
When looking at CURE, remember that "price return" and "total return" are different. One tells you about the share price, while the other includes cash payments. Also, because this fund is leveraged, its prices may move much faster than regular healthcare funds.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | HEALTH CARE SELECT SECTOR INDEX SWAP | n/a | 24.05% |
| 2 | DREYFUS GOVT CASH MAN INS | n/a | 19.83% |
| 3 | ELI LILLY AND CO | LLY | 10.64% |
| 4 | GOLDMAN SACHS FIN GOV 465 INSTITUT | n/a | 7.19% |
| 5 | JOHNSON & JOHNSON | JNJ | 6.97% |
| 6 | CASH | n/a | 5.47% |
| 7 | ABBVIE INC | ABBV | 5.01% |
| 8 | MERCK & CO INC | MRK | 4.04% |
| 9 | UNITEDHEALTH GROUP INC | UNH | 3.79% |
| 10 | AMGEN INC | AMGN | 2.54% |